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Abstract
Background: Computational models play an increasingly important role in the assessment and control of public
health crises, as demonstrated during the 2009 H1N1 influenza pandemic. Much research has been done in recent
years in the development of sophisticated data-driven models for realistic computer-based simulations of infectious
disease spreading. However, only a few computational tools are presently available for assessing scenarios,
predicting epidemic evolutions, and managing health emergencies that can benefit a broad audience of users
including policy makers and health institutions.
Results: We present “GLEaMviz”, a publicly available software system that simulates the spread of emerging
human-to-human infectious diseases across the world. The GLEaMviz tool comprises three components: the client
application, the proxy middleware, and the simulation engine. The latter two components constitute the GLEaMviz
server. The simulation engine leverages on the Global Epidemic and Mobility (GLEaM) framework, a stochastic
computational scheme that integrates worldwide high-resolution demographic and mobility data to simulate
disease spread on the global scale. The GLEaMviz design aims at maximizing flexibility in defining the disease
compartmental model and configuring the simulation scenario; it allows the user to set a variety of parameters
including: compartment-specific features, transition values, and environmental effects. The output is a dynamic map
and a corresponding set of charts that quantitatively describe the geo-temporal evolution of the disease. The
software is designed as a client-server system. The multi-platform client, which can be installed on the user’s local
machine, is used to set up simulations that will be executed on the server, thus avoiding specific requirements for
large computational capabilities on the user side.
Conclusions: The user-friendly graphical interface of the GLEaMviz tool, along with its high level of detail and the
realism of its embedded modeling approach, opens up the platform to simulate realistic epidemic scenarios. These
features make the GLEaMviz computational tool a convenient teaching/training tool as well as a first step toward
the development of a computational tool aimed at facilitating the use and exploitation of computational models
for the policy making and scenario analysis of infectious disease outbreaks.
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T h e2 0 0 9H 1 N 1i n f l u e n z ap a n d e m i ch i g h l i g h t e dt h e
importance of computational epidemic models for the
real-time analysis of the health emergency related to
the global spreading of new emerging infectious diseases
[1-3]. Realistic computational models are highly complex
and sophisticated, integrating substantial amounts of
data that characterize the population and geographical
context in order to attain superior accuracy, resolution,
and predictive power [4-10]. The challenge consists in
developing models that are able to capture the complex-
ity of the real world at various levels by taking advan-
tage of current information technology to provide an
in silico framework for testing control scenarios that can
anticipate the unfolding of an epidemic. At the same
time, these computational approaches should be trans-
lated into tools accessible by a broader set of users who
are the main actors in the decision-making process of
health policy, especially during an emergency like an
influenza pandemic. The tradeoff between realistic and
accurate descriptions of large-scale dynamics, flexibility,
computational feasibility, ease of use, and accessibility of
these tools creates a major challenge from both the
theoretical and the computational points of view
[4,5,11,12,10,13]. GLEaMviz is a client-server software
system that can model the world-wide spread of epi-
demics for human transmissible diseases like influenza-
like illnesses (ILI), offering extensive flexibility in the
design of the compartmental model and scenario setup,
including computationally-optimized numerical simula-
tions based on high-resolution global demographic and
mobility data. GLEaMviz makes use of a stochastic and
discrete computational scheme to model epidemic
spread called “GLEaM” - GLobal Epidemic and Mobility
model, presented in previously published work [6,3,14] -
which is based on a geo-referenced metapopulation
approach that considers 3,362 subpopulations in 220
countries of the world, as well as air travel flow connec-
tions and short-range commuting data. The software
includes a client application with a graphical user inter-
face (GUI) for setting up and executing simulations, and
retrieving and visualizing the results; the client applica-
tion is publicly downloadable. The server application
can be requested by public institutions and research
centers; conditions of use and possible restrictions will
be evaluated specifically.
The tool is currently not suitable for the simulation of
vector-borne diseases, infection transmission depending
on local contact patterns such as sexually transmitted
diseases and diseases with a time scale that would make
demographic effects relevant. The tool, however, allows
the introduction of mitigation policies at the global
level. Localized intervention in space or time can be
implemented in the GLEaM model and their introduc-
tion in the GLEaMviz computational tool are planned
for future releases.
Only a few computational tools are currently available
to the public for the analysis and modeling of epidemics.
These range from very simple spreadsheet-based models
aimed at providing quick estimates for the number of
patients and hospitalizations during a pandemic (see e.g.
FluSurge [15]) to more complicated tools based on
increasingly sophisticated simulation approaches
[11,16,12,10,13,5]. These tools differ in their underlying
modeling approaches and in the implementation, flex-
ibility, and accessibility of the software itself.
InfluSim is a tool that provides a visual interface to
simulate an epidemic with a deterministic compartmen-
t a lm o d e li nas i n g l ep o p u l a t i o n[ 1 1 ] .T h em o d e l
includes age structure and explicit sojourn times with
different stages in each compartment, extending an
SEIR compartmentalization to include hospitalizations
and intervention measures. The software provides the
infectious disease dynamics and the user can set para-
meter values and add or remove interventions. However,
no spatial structure or other forms of heterogeneity and
stochasticity are considered in the model.
On the other hand agent-based models describe the
stochastic propagation of a disease at the individual
level, thus taking into account the explicit social and
spatial structure of the population under consideration.
CommunityFlu is a software tool that simulates the
spread of influenza in a structured population of
approximately 1,000 households with 2,500 persons [13].
User interaction with the software is limited to the
spreadsheet portion of the program, where one can
choose the type of intervention and other parameters
describing the disease and the population.
A larger population is considered in FluTe,ap u b l i c l y
available tool for the stochastic simulation of an epi-
demic in the United States at the level of individuals
[10]. The model is based on a synthetic population,
structured in a hierarchy of mixing social groups includ-
ing households, household clusters, neighborhoods, and
nation-wide communities. FluTe comes with a config-
uration file in text format that can be modified by an
expert user to set various parameters such as the initia-
tion of the epidemic, the reproductive number, and the
interventions considered. No GUI is provided, and the
output of the simulations is given in the form of text
files that must be analyzed through additional software.
EpiFast involves a parallel algorithm implemented
using a master-slave approach which allows for scalabil-
ity on distributed memory systems, from the generation
of synthetic population aggregated in mixing groups to
the explicit representation of the contact patterns
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Fast tool allows for the detailed representation and
simulation of the disease on social contact networks
among individuals that dynamically evolve in time and
adapt to actions taken by individuals and public health
interventions. The algorithm is coupled with a web-
based GUI and the middleware system Didactic, which
allows users to specify the simulation setup, execute the
simulation, and visualize the results via plots. Epidemic
models and interventions are pre-configured, and the
system can scale up to simulate a population of a large
metropolitan area on the order of tens of millions of
inhabitants.
Another class of models focuses on the global scale,
by using a metapopulation approach in which the popu-
lation is spatially structured into patches or subpopula-
tions (e.g. cities) where individuals mix. These patches
are connected by mobility patterns of individuals. In this
vein two tools are currently available. The Global Epi-
demic Model (GEM) uses a metapopulation approach
based on an airline network comprised of 155 major
metropolitan areas in the world for the stochastic simu-
lation of an influenza-like illness [16]. The tool consists
of a Java applet in which the user can simulate a
hypothetical H1N1 outbreak and test pre-configured
intervention strategies. The compartmentalization is set
to an SEIR model, and the parameterization can be
modified in the full or stand-alone mode, but not cur-
rently in the Java applet.
The Spatiotemporal Epidemiological Modeler (STEM)
is a modeling system for the simulation of the spread
of an infectious disease in a spatially structured popu-
lation [16]. Contrary to other approaches, STEM is
based on an extensible software platform, which pro-
motes the contribution of data and algorithms by
users. The resulting framework therefore merges data-
sets and approaches and its detail and realism depend
on continuous developments and contributions. How-
ever, these are obtained from a variety of sources and
are provided in different formats and standards, thus
resulting in possible problems related to the integra-
tion and merging of datasets. Such issues are left to
the user to resolve.
The existing tools described above thus offer the
opportunity to use highly sophisticated data-driven
approaches at the expense of flexibility and ease of use
by non-experts on the one hand, or very simplified
models with user-friendly GUIs and no specific compu-
tational requirements on the other. Our approach aims
at optimizing the balance of complex and sophisticated
data-driven epidemic modeling at the global scale while
maintaining an accessible computational speed and
overall flexibility in the description of the simulation
scenario, including the compartmental model, transition
rates, intervention measures, and outbreak conditions by
means of a user-friendly GUI.
In the GLEaMviz tool the setup of the simulations is
highly flexible in that the user can design arbitrary dis-
ease compartmental models, thus allowing an extensive
range of human-to-human infectious diseases and inter-
vention strategies to be considered. The user interface
has been designed in order to easily define both features
specific to each compartment, such as the mobility of
classes of individuals, and general environmental effects,
such as seasonality for diseases like influenza. In addi-
tion, the user can define the initial settings that charac-
terize the initial geographical and temporal conditions,
the immunity profile of the population, and other para-
meters including but not limited to: the definition of an
o u t b r e a kc o n d i t i o ni nag i v e nc o u n t r y ;t h en u m b e ro f
stochastic runs to be performed; and the total duration
of each simulation. The tool allows the production of
global spreading scenarios with geographical high reso-
lution by just interacting with the graphic user interface.
While an expert input wouldb er e q u i r e dt oi n t e r p r e t
and discuss the results obtained with the software, the
present computational platform facilitates the generation
and analysis of scenarios from intensive data-driven
simulations. The tool can be deployed both in training
activities as well as to facilitate the use of large-scale
computational modeling of infectious diseases in
the discussion between modelers and public health
stakeholders.
The paper is organized as follows. The “Implementa-
tion” section describes the software application archi-
tecture and its major components, including the
computational model GLEaM. The “Results and dis-
cussion” section presents in detail the GLEaMviz client
and its components that allow for software-user inter-
action, including an application of the Simulator to an
Influenza-like-illness scenario.
Implementation
The top-level architecture of the GLEaMviz tool com-
prises three components: the GLEaMviz client application,
the GLEaMviz proxy middleware, and the simulation
engine. The latter two components constitute the GLEaM-
viz server, as shown in Figure 1.
Users interact with the GLEaMviz system by means of
the client application, which provides graphical user-
interfaces for designing and managing the simulations,
as well as visualizing the results. The clients, however,
do not themselves run the simulations. Instead they
establish a connection with the GLEaMviz proxy mid-
dleware to request the execution of a simulation by the
server. Multiple clients can use the same server concur-
rently. Upon receipt of requests to run a simulation, the
middleware starts the simulation engine instances
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tus. Once the simulations are completed, the GLEaMviz
proxy middleware collects and manages the resulting
simulation data to be served back to the clients. A sche-
matic diagram of the workflow between client and ser-
ver is shown in Figure 2.
This client-server model allows for full flexibility in its
deployment; the client and server can be installed on the
same machine, or on different machines connected by a
local area network or the Internet. The two-part decom-
position of the server in terms of middleware and engines
additionally allows for advanced high-volume setups in
which the middleware server distributes the engine
instances over a number of machines, such as those in a
cluster or cloud. This architecture thus ensures high
speed in large-scale simulations and does not rely on the
CPU-specific availability accessible by the user.
The GLEaMviz simulation engine uses a stochastic
metapopulation approach [17-19,2,20-22,16] that con-
siders data-driven schemes for the short-range and
GLEaMviz Client GLEaMviz Server
Design the compartmental model of the 
infectious disease in the Model Builder.
1
Conﬁgure the simulation of 
the world-wide epidemic 
spreading in the 
Simulation Wizard.
2
Submit the simulation for execution 
by the Engine on the server.
3
Inspect the results of a simulation 
in the interactive Visualization.
5 Inspect all simulations 
and retrieve results in the 
Simulations History.
4
Figure 2 The principal GLEaMviz tool workflow with the GLEaMviz components involved in each step. The compartmental model of the
infectious disease is created in the Model Builder. Next, the Simulation Wizard is used to configure the simulation and submit it for execution by
the Engine on the server. The Simulation History keeps track of the submitted simulations and retrieves the simulation results when they
become available. The simulation results are finally inspected in the interactive Visualization.
GLEaMviz client GLEaMviz server
GLEaMsim GLEaMsim GLE GLE GLE M aMs aMsi im im
wrapper
client proxy
core
(GLEaM)
simulation engine
Figure 1 The GLEaMviz tool system involves one or more
GLEaMviz clients that interact with a GLEaMviz server over a
TCP connection. The server consists of a GLEaMviz proxy
middleware component and a number of GLEaMviz simulation
engines. The middleware component handles the interactions with
the clients and manages the engine instances. Each submitted
simulation is performed by one GLEaMviz simulation engine
instance, which consists of a wrapper that launches the actual
simulation cores, one for each run, and performs statistical analysis
on the aggregated results.
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tion level, coupled with coarse-grained techniques to
describe the infection dynamics within each subpopula-
tion [6,14]. The basic mechanism for epidemic propaga-
tion occurs at multiple scales. Individuals interact
within each subpopulation and may contract the disease
if an outbreak is taking place in that subpopulation. By
travelling while infected, individuals can carry the
pathogen to a non-infected region of the world, thus
starting a new outbreak and shaping the spatial spread
of the disease.
The basic structure of GLEaM consists of three dis-
tinct layers - the population layer, the mobility layer,
and the epidemic layer (see Figure 3) [6,14].
The population layer is based on the high-resolution
population database of the Gridded Population of the
World project by the Socio-Economic Data and Applica-
tions Center (SEDAC) [23] that estimates population
with a granularity given by a lattice of cells covering the
whole planet at a resolution of 15 × 15 minutes of arc.
The mobility layer integrates short-range and long-
range transportation data. Long-range air travel mobility
i sb a s e do nt r a v e lf l o wd a t ao b t a i n e df r o mt h eI n t e r n a -
tional Air Transport Association (IATA [24]) and the
Official Airline Guide (OAG [25]) databases, which con-
tain the list of worldwide airport pairs connected by
direct flights and the number of available seats on any
given connection [26]. The combination of the popula-
tion and mobility layers allows for the subdivision of the
world into geo-referenced census areas obtained by a
Voronoi tessellation procedure around transportation
hubs. These census areas define the subpopulations of
the metapopulation modeling structure, identifying
3,362 subpopulations centered on IATA airports in
220 different countries. The model simulates the mobi-
lity of individuals between these subpopulations using
a stochastic procedure defined by the airline transpor-
tation data [6]. Short-range mobility considers com-
muting patterns between adjacent subpopulations
b a s e do nd a t ac o l l e c t e da n da n a l y z e df r o mm o r et h a n
30 countries in 5 continents across the world [6]. It is
modeled with a time-scale separation approach that
defines the effective force of infections in connected
subpopulations [6,27,28].
On top of the population and mobility layers lies the
epidemic layer, which defines the disease and population
dynamics. The infection dynamics takes place within
each subpopulation and assumes a compartmentaliza-
tion [29] that the user can define according to the infec-
tious disease under study and the intervention measures
being considered. All transitions between compartments
are modeled through binomial and multinomial pro-
cesses to preserve the discrete and stochastic nature of
the processes. The user can also specify the initial out-
break conditions that characterize the spreading sce-
nario under study, enabling the seeding of the epidemic
in any geographical census area in the world and defin-
ing the immunity profile of the population at initiation.
Seasonality effects are still an open problem in the
transmission of ILI diseases. In order to include the
effect of seasonality on the observed pattern of ILI dis-
eases, we use a standard empirical approach in which
Population layer Short-range mobility layer Long-range mobility layer
101
105
101
105
census areas commuting air travel
airports
Figure 3 The three population and mobility data layers in GLEaM.T h epopulation layer consists of demographic data at a resolution of
15 × 15 minutes of arc, organized in geo-referenced census areas obtained with a Voronoi tessellation procedure around transportation hubs.
The short-range mobility layer covers commuting patterns between adjacent subpopulations based on data collected and analyzed from more
than 30 countries on 5 continents across the world, modeled with a time-scale separation approach that defines the effective force of infections
in connected subpopulations. The long-range mobility layer covers the air travel flow, measured in available seats between worldwide airport
pairs connected by direct flights.
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Page 5 of 14seasonality is modeled by a forcing that reduces the
b a s i cr e p r o d u c t i v en u m b e rb yaf a c t o ramin ranging
f r o m0 . 1t o1( n os e a s o n a l i t y )[ 2 0 ] .T h ef o r c i n gi s
described by a sinusoidal function of 12 months-period
that reaches its peak during Winter time and its mini-
mum during Summer time in each Hemisphere, with
the two Hemispheres with opposite phases.
Given the population and mobility data, infection
dynamics parameters, and initial conditions, GLEaM
performs the simulation of stochastic realizations of the
worldwide unfolding of the epidemic. From these
in silico epidemics a variety of information can be gath-
ered, such as prevalence, morbidity, number of second-
ary cases, number of imported cases, hospitalized
patients, amounts of drugs used, and other quantities
for each subpopulation with a time resolution of 1 day.
GLEaM has been under continuous development since
2005 and during these years it has been used: to assess
the role of short-range and long-range mobility in epi-
demic spread [30,31,6]; to retrospectively analyze the
SARS outbreak of 2002-2003 in order to investigate the
predictive power of the model [22]; to explore global
health strategies for controlling an emerging influenza
pandemic with pharmaceutical interventions under
logistical constraints [21]; and more recently to estimate
the seasonal transmission potential of the 2009 H1N1
influenza pandemic during the early phase of the out-
break to provide predictions for the activity peaks in the
Northern Hemisphere [3,32].
The GLEaMviz simulation engine consists of a core
that executes the simulations and a wrapper that pre-
pares the execution based on the configuration relayed
from the client by the GLEaMviz proxy middleware. The
engine can perform either single-run or multi-run simu-
lations. The single-run involves only a single stochastic
realization for a given configuration setup and a random
seed. The multi-run simulation involves a number of sto-
chastic realizations as set by the user and performed by
t h ec o r e( s e et h ef o l l o w i n gS ection), each with the same
configuration but with a different random seed. The
results of the multi-run simulation are then aggregated
and statistically analyzed by the wrapper code.
The simulation engine writes the results to files and
uses lock files to signal its status to the middleware
component. The core is written in C++, resulting in a
fast and efficient engine that allows the execution of a
single stochastic simulation of a 1-year epidemic with
a standard SEIR model in a couple of minutes on a
high-end desktop computer. The wrapper code is writ-
ten in Python [33]. The server components can be
installed on most UNIX-like operating systems such as
Linux, BSD, Mac OS X, etc.
The GLEaMviz proxy middleware is the server com-
ponent that mediates between clients and simulation
engines. It accepts TCP connections from clients and
handles requests relayed over these connections, provid-
ing client authorization management.
A basic access control mechanism is implemented that
associates a specific client with the simulations it
launches by issuing a private simulation identifier key
upon submission. Users can only retrieve the results of
the simulations they launched, or simulations for which
they have obtained the simulation definition file -con-
taining the private simulation identifier key- from the
original submitter.
Upon receipt of a request to execute a simulation, the
middleware sets up the proper system environment and
then launches an instance of the simulation engine with
the appropriate configuration and parameters according
to the instructions received from the client. For single-
run simulations, the daily results are incrementally
served back to the client while the simulation is being
executed. This allows for the immediate visualization of
the spreading pattern, as described in “Visualization
interface” Subsection. For multi-run simulations the
results are statistically analyzed after all runs are fin-
ished, and the client has to explicitly request the retrie-
val of the results once they become available. The
GLEaMviz proxy server component can be configured
to keep the simulation data indefinitely or to schedule
the cleanup of old simulations after a certain period of
time. Multi-run metadata is stored in an internal object
that is serialized on a system file, ensuring that authori-
zation information is safely kept after a server shutdown
or failure. The GLEaMviz proxy component additionally
provides control features such as accepting administra-
tive requests at runtime in order to manage stored
simulations or to modify several configuration para-
meters like the number of simultaneous connections
allowed, the number of simultaneous simulations per
client, the session timeout, etc.
The middleware server is written in Python [33] and
uses the Twisted Matrix library suite [34] for its net-
working functionality. Client and server communicate
using a special purpose protocol, which provides com-
mands for session handling and simulation management.
Commands and data are binary encoded using Adobe
Action Message Format (AMF3) in order to minimize
bandwidth needs.
The GLEaMviz client is a desktop application by
which users interact with the GLEaMviz tool. It provides
GUIs for its four main functions: 1) the design of com-
partmental models that define the infection dynamics; 2)
the configuration of the simulation parameters; 3) the
visualization of the simulation results; and 4) the man-
agement of the user’s collection of simulations. In the
following Section we describe these components in
detail.
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form [35] and the Flex framework [36] and can thus be
deployed on diverse operating systems, including several
Windows versions, Mac OS X, and several common
Linux distributions. The GLEaMviz client has a built-in
updating mechanism to check for the latest updates and
developments and prompts the user to automatically
download them. It also offers a menu of configuration
options of the interface that allows the user to custo-
mize preferences about data storage, visualization
options, the server connection, and others.
Results and Discussion
The software system presented above is operated
through the GLEaMviz client, which provides the user
interface: the part of the tool actually experienced on
the user side. The GLEaMviz client integrates different
modules that allow the management of the entire pro-
cess flow from the definition of the model to the visuali-
zation of the results. In the following we will describe
the various components and provide the reader with a
user study example.
Model Builder
The Model Builder provides a visual modeling tool for
designing arbitrary compartmental models, ranging from
simple SIR models to complex compartmentalization in
which multiple interventions can be considered along with
disease-associated complications and other effects.
(An example can be found in previous work [37].) A snap-
shot of the Model Builder window is shown in Figure 4.
The models are represented as flow diagrams with sty-
lized box shapes that represent compartments and direc-
ted edges that represent transitions, which is consistent
with standard representations of compartmental models
in the literature. Through simple operations like ‘click
and drag’ it is possible to create any structure with full
flexibility in the design of the compartmentalization; the
user is not restricted to a given set of pre-loaded com-
partments or transition dynamics. The interactive inter-
face provided by the Model Builder enables the user to
define the compartment label, the mobility constraints
that apply (e.g. allowed/not allowed to travel by air or by
ground), whether the compartment refers to clinical
cases, as well as the color and position of their represen-
tation in the diagram (see Figure 5). This allows the user
to model many kinds of human-to-human infectious dis-
eases, in particular respiratory and influenza-like diseases.
Transitions from one compartment to another can be
of two types: infection transitions or spontaneous transi-
tions. Examples of spontaneous transitions include the
transitions from latent to infectious individuals and
from infectious to recovered individuals. An infection
transition, on the other hand, generates new infected
individuals. In GLEaM we consider a homogeneous mix-
ing assumption in each subpopulation so that the
expected number of new infections generated by I infec-
tious individuals in a population with S susceptible
Model Builder
Hints
Canvas Variables list
Inconsistencies
Menu
Figure 4 The compartmental Model Builder allows the user to define the dynamics of the infection by creating population
compartments and specifying the infectious and the spontaneous transitions that occur between them. The Model Builder provides an
interactive diagram of the compartmental model, a table with the values for the variables used in the model, a list of current inconsistencies in
the model, and a panel that provides concise descriptions on the various functionalities in the interactive diagram.
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N
,w h e r eN is the total size of
the subpopulation. The GLEaM simulation engine con-
siders discrete individuals. All its transition processes
are both stochastic and discrete, and are modeled
through binomial and multinomial processes.
Transitions can be visually added by dragging a marker
from the source to the target compartment. Spontaneous
transitions are annotated with their rates, which can be
modified interactively. Infection transitions are accompa-
nied with a representation of the infection’ss o u r c ec o m -
partment and the applicable rate (i.e. b in the example
above), which can also be modified in an interactive way.
The rates can be expressed in terms of a constant value or
in terms of a variable whose value needs to be specified in
the variables table, as shown in Figure 4. The value can
also be expressed by simple algebraic expressions.
The client automatically checks for and reports incon-
sistencies in the model in order to assist the user in the
design process (see bottom right window in Figure 4).
Models can be exported to XML files and stored
locally, allowing the user to load a model later, modify
it, and share it with other users. The diagram represen-
tation can be exported as a PDF or SVG file for use in
documentation or publications. A few examples of
compartmental models are available for download from
the Simulator website.
Simulation Wizard
The Simulation Wizard provides a sequence of panels
that leads the user through the definition of several con-
figuration parameters that characterize the simulation.
Figure 6 shows some of these panels. The consecutive
steps of the configuration are as follows:
￿Choice of the type of the simulation (panel a)
The user is prompted with three options: create a new
single-run simulation or a new multi-run simulation
from scratch, or a new one based on a saved simulation
previously stored in a file.
￿Compartmental model selection and editing
(panel b)
The user can design a new compartmental model,
modify the current compartmental model (when deriv-
ing it from an existing simulation), or load a model
compartmentalization from a file.
￿Definition of the simulation parameters (panel c)
The user is asked to specify various settings and para-
meter values for the simulation, including, e.g., the num-
ber of runs to perform (only accessible in the case of a
multi-run), the initial date of the simulation, the length
of the simulation (in terms of days), whether or not sea-
sonality effects should be considered, the airplane occu-
pancy rate, the commuting time, the conditions for the
definition of an outbreak, and others.
￿Initial assignment of the simulation (panel d)
Here the user assigns the initial distribution of the
population amongst compartments, defining the immu-
nity profile of the global population on the starting date.
￿Definition of the outbreak start (panel e)
This panel allows the user to define the initial condi-
tions of the epidemic by selecting the city (or cities)
seeded with the infection.
￿Selection of output results (panel f)
Here the user selects the compartments that will con-
stitute the output provided by the client at the end of
the simulation. The corresponding data will be shown in
the Visualization Window and made available for
download.
When all the above configuration settings are defined,
the user can submit the simulation to the GLEaMviz
server for execution. This will automatically add the
simulation to the user’s Simulations History. It is
furthermore possible to save the definition of the simu-
lation setup to a local file, which can be imported again
later or shared with other users.
Simulations History
The Simulations History is the main window of the cli-
ent and provides an overview of the simulations that the
Compartments
Transitions
infector
infection edge
susceptible compartment
infection 
transition target
add infector
delete infector
select the infector 
compartment
transition 
variables
click or drag to add infection transition
click or drag to add spontaneous transition
allow/disallow air travel
allow/disallow commuting
remove compartment
change color
clinical cases yes/no
Figure 5 The interactive compartmental model diagram in the
Model Builder represents the compartments and the
transitions. Various user interface elements in these representations
allow the user to manipulate the model occurring to his/her needs.
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Page 8 of 14user has designed and/or submitted, in addition to pro-
viding access to the Model Builder, the Simulation
Wizard, and the Visualization Component. The overview
panel shown in Figure 7 lists the simulation identifier,
the submission date and time, the simulation type
(i.e., single or multi-run), the execution status (i.e., initi-
alized, start pending, started, aborted, complete, failed,
or stop pending) and the results status (i.e., none,
retrieve pending, retrieving, stop retrieve pending, com-
plete, or stored locally). Additional File 1 provides a
detailed explanation of all these values.
A number of context-dependent command buttons
are available once a simulation from the list is selected.
Those buttons allow the user to control the simulation
execution, retrieve the results from the server and visua-
lize them, clone and edit the simulation to perform a
new execution, save the simulation definition or the out-
put data to the local machine (in order to analyze the
obtained data with other tools, for example), and
remove the simulation. In addition to exporting the
compartmental model (see the “Model Builder” Subsec-
tion) the user can export a complete configuration of a
simulation that includes the compartmental model and
the entire simulation setup to a local file, which can be
imported again later or shared with other users.
Visualization interface
Once the execution of a simulation is finished and the
results have been retrieved from the server, the client
can display the results in the form of an interactive
visualization of the geo-temporal evolution of the epi-
demic. This visualization consists of a temporal and geo-
graphic mapping of the results accompanied by a set of
graphs (see Figure 8). The geographic mapping involves
a zoomable multi-scale map on which the cells of the
population layer are colored according to the number of
new cases of the quantity that is being displayed. Several
visualization features can be customized by clicking on
the gear icon and opening the settings widget. It is pos-
sible to zoom in and out and pan by means of the inter-
face at the top left of the map. Dragging the map with
Figure 7 The main window contains the main menu and the
Simulations History, which provides an overview of all the
simulations set up by the user, and a contextual menu with
the applicable operations.
Figure 6 The Simulation Wizard provides a sequence of panels that leads the user through the definition of the settings and
parameters that characterize the simulation. These panels prompt the user to specify: (a) the type of simulation; (b) the compartmental
model; (c) the simulation parameters; (d) the initial distribution of the population amongst the compartments; (e) the initial conditions of the
start of the epidemic outbreak; and (f) the compartments considered for the results gathered at the end of the simulation.
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Page 9 of 14the mouse (on a location where there are no basin
marks) can also pan the visualization. All the widgets
and the graphs displayed over the map can be re-posi-
tioned according to the user’s preferences by clicking
and dragging the unused space in the title bar.
The color coding of the map represents the number of
cases on a particular day. The time evolution of the epi-
demic can be shown as a movie, or in the form of daily
states by moving forward or backward by one day at a
time. For single-run simulations it is also possible to
show the airline transportation of the ‘seeding’ indivi-
duals by drawing the traveling edge between the origin
and destination cities. In the case where the output quan-
tity is a subset of the infectious compartments, the edges
show the actual seeding of the infection. Note that the
evolution of the epidemic depends strongly on the model
definition. For example, it is possible that some basins
are infected by a latent individual that later develops the
disease. In this case no seeding flight will be shown if
only infectious compartments are selected as output.
Beside the geographical map, the Visualization Win-
dow displays two charts. One chart shows the number of
new cases per 1,000 over time (incidence), and the other
shows the cumulative number of new cases per 1,000
over time (size). For multi-run simulations, median
values and corresponding 95% confidence intervals are
shown. The menu above each chart combo lets the user
choose the context for which the corresponding charts
show incidence and size data. This context is either:
global, one of three hemispheres, one continent, one
region, one country, or one city. The currently selected
day is marked by a vertical line in these plots, and the
day number, counted from the initial date selected for
the simulation, is shown by side of the time slider.
User study example
Here we present an example application of the GLEaMviz
tool to study a realistic scenario for the mitigation of an
emerging influenza pandemic. Disease-control programs
foresee the use of antiviral drugs for treatment and short-
term prophylaxis until a vaccine becomes available [38].
The implementation of these interventions rely both on
logistical constraints [21,39] - related, e.g., to the availabil-
ity of drugs - and on the characteristics of the infection,
including the severity of the disease and the virus’s poten-
tial to develop resistance to the drugs [40].
Here we focus on the mitigation effects of systematic
antiviral (AV) treatment in delaying the activity peak
and reducing attack rate [41-43,7,8,39,40,3], and assume
that all countries have access to AV stockpiles. We con-
sider a scenario based on the 2009 H1N1 influenza pan-
demic outbreak and feed the Simulator with the set of
parameters and initial conditions that have been esti-
mated for that outbreak through a Maximum Likelihood
Estimate by using the GLEaM model [3]. The results
provided by the present example are not meant to be
compared with those contained in the full analysis car-
ried out with GLEaM [3] due to the fact that in the
Figure 8 The simulation results can be inspected in an interactive visualization of the geo-temporal evolution of the epidemic.T h e
map shows the state of the epidemic on a particular day with infected population cells color-coded according to the number of new cases of
the quantity that is being displayed. Pop-ups provide more details upon request for each city basin. The zoomable multi-scale map allows the
user to get a global overview, or to focus on a part of the world. The media-player-like interface at the bottom is used to select the day of
interest, or show the evolution of the epidemic like a movie. Two sets of charts on the right show the incidence curve and the cumulative size
of the epidemics for selectable areas of interest.
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tion strategies that were put in place during the early
phase of the outbreak, such as the sanitary control mea-
sures implemented in Mexico [3,44], or the observed
reduction in international travel to/from Mexico [45].
Indeed, the current version of GLEaMviz does not allow
for interventions that are geographically and/or tempo-
rally dependent. However, these features are currently
under development and will be available in the next
software release. For this reason the simulation scenario
that we study in this application of the Simulator does
not aim to realistically reproduce the timing of the
spreading pattern of the 2009 H1N1 pandemic. The
results reported here ought to be considered as an
assessment of the mitigating impact of AV treatment
alone, based on the initial conditions estimated for the
H1N1 outbreak, and assuming the implementation of
the same AV protocol in all countries of the world.
We adopt a SEIR-like compartmentalization to model
influenza-like illnesses [29] in which we include the sys-
tematic successful treatment of 30% of the symptomatic
infectious individuals (see Figure 9). The efficacy of the
Figure 9 Compartmental structure in each subpopulation in the intervention scenario. A modified Susceptible-Latent-Infectious-Recovered
model is considered, to take into account asymptomatic infections, traveling behavior while ill, and use of antiviral drugs as a pharmaceutical
measure. In particular, infectious individuals are subdivided into: asymptomatic (Infectious_a), symptomatic individuals who travel while ill
(Infectious_s_t), symptomatic individuals who restrict themselves from travel while ill (Infectious_s_nt), symptomatic individuals who undergo the
antiviral treatment (Infectious_AVT). A susceptible individual interacting with an infectious person may contract the illness with rate beta and
enter the latent compartment where he/she is infected but not yet infectious. The infection rate is rescaled by a factor ra in case of
asymptomatic infection [41,46], and by a factor rAVT in case of a treated infection. At the end of the latency period, of average duration equal to
eps
-1, each latent individual becomes infectious, showing symptoms with probability 1-pa, whereas becoming asymptomatic with probability pa
[41,46]. Change in travelling behavior after the onset of symptoms is modeled with probability pt set to 50% that individuals would stop
travelling when ill [41]. Infectious individuals recover permanently after an average infectious period mu
-1 equal to 2.5 days. We assume the
antiviral treatment regimen to be administered to a 30% fraction (i.e. pAVT = 0.3) of the symptomatic infectious individuals within one day from
the onset of symptoms, reducing the infectiousness and shortening the infectious period of 1 day. [41,42].
Broeck et al. BMC Infectious Diseases 2011, 11:37
http://www.biomedcentral.com/1471-2334/11/37
Page 11 of 14AV treatment is accounted for in the model by a 62%
reduction in the transmissibility of the disease by an
infected person under AV treatment when AV drugs are
administered in a timely fashion [41,42]. We assume
t h a tt h ed r u g sa r ea d m i n i s t e r e dw i t h i n1d a yo ft h e
onset of symptoms and that the AV treatment reduces
the infectious period by 1 day [41,42]. The scenario with
AV treatment is compared to the baseline case in which
no intervention is considered, i.e. the probability of
treatment is set equal to 0 in all countries.
The GLEaMviz simulation results are shown in
Figure 10 where the incidence profiles in two different
regions of the world, North America and Western Eur-
ope, are shown for both the baseline case and the inter-
vention scenario with AV treatment. The results refer to
the median (solid line) and 95% reference range (shaded
area) obtained from 100 stochastic realizations of each
scenario starting from the same initial conditions. The
resulting incidence profiles of the baseline case peak at
around mid-November and the end of November 2009
in the US and Western Europe, respectively. These
results show an anticipated peak of activity for the
Northern Hemisphere with respect to the expected peak
time of seasonal influenza. In order to make a more
accurate comparison with the surveillance data in these
regions, we should rely on the predictions provided by
models that can take into account the full spectrum of
strategies that were put in place during the 2009 H1N1
outbreak, viz. the predictions obtained by GLEaM [3].
In the case of a rapid and efficient implementation of
the AV treatment protocol at the worldwide level, a
delay of about 6 weeks would be obtained in the regions
under study, a result that could be essential in gaining
time to deploy vaccination campaigns targeting high-risk
groups and essential services. In addition, the GLEaMviz
tool provides simulated results for the number of AV
drugs used during the evolution of the outbreak. If we
assume treatment delivery and successful administration
of the drugs to 30% of the symptomatic cases per day,
the number of AV drugs required at the activity peak in
Western Europe would be 4.5 courses per 1,000 persons,
and the size of the stockpile needed after the first year
since the start of the pandemic would be about 18% of
the population. Again, we assume a homogeneous treat-
ment protocol for all countries in the world; results may
vary from country to country depending on the specific
evolution of the pandemic at the national level.
Conclusions
Computer-based simulations provide an additional
instrument for emerging infectious-disease preparedness
and control, allowing the exploration of diverse scenar-
ios and the evaluation of the impact and efficacy of var-
ious intervention strategies. Here we have presented a
computational tool for the simulation of emerging ILI
infectious diseases at the global scale based on a data-
driven spatial epidemic and mobility model that offers
an innovative solution in terms of flexibility, realism,
and computational efficiency, and provides access to
sophisticated computational models in teaching/training
settings and in the use and exploitation of large-scale
simulations in public health scenario analysis.
Availability and requirements
Project name: GLEaMviz Simulator v2.6
Project homepage: http://www.gleamviz.org/simulator/
Operating systems (client application): Windows (XP,
Vista, 7), Mac OS X, Linux.
Programming language: C++ (GLEaMsim core),
Python (GLEaMproxy, GLEaMsim wrapper), Action-
Script (GLEaMviz)
Other requirements (client application): Adobe AIR
runtime, at least 200 Mb of free disk space.
License: SaaS
Baseline scenario Scenario with AV
Figure 10 Simulated incidence profiles for North America and
Western Europe in the baseline case (left panels) and in the
AV treatment scenario (right panels). The plots are extracted
from the GLEaMviz tool visualization. In the upper plots of each pair
the curves and shaded areas correspond to the median and 95%
reference range of 100 stochastic runs, respectively. The lower
curves show the cumulative size of the infection. The dashed
vertical line marks the same date for each scenario, clearly showing
the shift in the epidemic spreading due to the AV treatment.
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Page 12 of 14Any restrictions to use by non-academics: None.
The server application can be requested by public
institutions and research centers; conditions of use and
possible restrictions will be evaluated specifically.
Additional material
Additional file 1: The GLEaMviz computational tool: Additional File.
This file includes information for installing the GLEaMviz Client and
details of the features of its various components.
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